Mortality in patients with giant cell arteritis

Rheumatology (United Kingdom)

Volumn 54, Issue 1, 2014, Pages 139-143

  Baslund, Bo ^a   Helleberg, Marie ^a   Faurschou, Mikkel ^a   Obel, Niels ^a  

^a University of Copenhagen   (Denmark)

Author keywords

Aortic aneurysm; Cancer; Cardiovascular disease; Epidemiology; GCA; Mortality

Indexed keywords

AGED; AORTA ANEURYSM; ARTICLE; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; DIGESTIVE SYSTEM DISEASE; FEMALE; FOLLOW UP; GIANT CELL ARTERITIS; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION RESEARCH; PRIORITY JOURNAL; RISK FACTOR;

EID: 84928735842     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keu303     Document Type: Article

References (20)

1. Salvarani C, Cantini F, Boiardi L, Hunder GG. Polymyalgia rheumatica and giant cell arteritis. N Engl J Med 2002;347: 261-71.
2. Espitia O, Neel A, Leux C et al. Giant cell arteritis with or without aortitis at diagnosis. A retrospective study of 22 patients with longterm followup. J Rheumatol 2012;39: 2157-62.
3. Prieto-Gonzalez S, Arguis P, Garcia-Martinez A et al. Large vessel involvement in biopsy-proven giant cell arteritis: prospective study in 40 newly diagnosed patients using CT angiography. Ann Rheum Dis 2012;71: 1170-6.
4. Evans JM, O'Fallon WM, Hunder GG. Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis: a population-based study. Ann Intern Med 1995; 122:502-7.
5. Nuenninghoff DM, Hunder GG, Christianson TJH, McClelland RL, Matteson EL. Mortality of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum 2003;48:3532-7.
6. Gonzalez-Gay MA, Garcia-Porrua C, Piñeiro A et al. Aortic aneurysm and dissection in patients with biopsy-proven giant cell arteritis from northwestern Spain: a populationbased study. Medicine 2004;83:335-41.
7. Gonzalez-Gay MA, Vazquez-Rodriguez TR, Gomez-Acebo I et al. Strokes at time of disease diagnosis in a series of 287 patients with biopsy-proven giant cell arteritis. Medicine 2009;88:227-35.
8. Nordborg E, Bengtsson BA. Death rates and causes of death in 284 consecutive patients with giant cell arteritis confirmed by biopsy. BMJ 1989;299:549-50.
9. Matteson EL, Gold KN, Bloch DA, Hunder GG. Long-term survival of patients with giant cell arteritis in the American College of Rheumatology giant cell arteritis classification criteria cohort. Am J Med 1996;100:193-6.
10. Rajala SA, Ahvenainen JE, Mattila KJ, Saarni MI. Incidence and survival rate in cases of biopsy-proven temporal arteritis. Scand J Rheumatol 1993;22:289-91.
11. González-Gay MA, Blanco R, Abraira V et al. Giant cell arteritis in Lugo, Spain, is associated with low longterm mortality. J Rheumatol 1997;24:2171-6.
12. Gran JT, Myklebust G, Wilsgaard T et al. Survival in polymyalgia rheumatica and temporal arteritis: a study of 398 cases and matched population controls. Rheumatology 2001;40:1238-42.
13. Bisgård C, Sloth H, Keiding N, Juel K. Excess mortality in giant cell arteritis. J Intern Med 1991;230: 119-23.
14. Uddhammar A, Eriksson A-L, Nyström L, Stenling R, Rantapää-Dahlqvist S. Increased mortality due to cardiovascular disease in patients with giant cell arteritis in northern Sweden. J Rheumatol 2002;29:737-42.
15. Crow RW, Katz BJ, Warner JEA et al. Giant cell arteritis and mortality. J Gerontol A Biol Sci Med Sci 2009;64A: 365-9.
16. Bengtsson BA, Malmvall BE. Prognosis of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. A follow-up study on ninety patients treated with corticosteroids. Acta Med Scand 1981;209:337-45.
17. Kermani TA, Warrington KJ, Crowson CS et al. Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosis. Ann Rheum Dis 2012;72:1989-94.
18. Salvarani C, Pipitone N, Versari A, Hunder GG. Clinical features of polymyalgia rheumatica and giant cell arteritis. Nat Rev Rheumatol 2012;8:509-21.
19. Kermani TA, Schäfer VS, Crowson CS et al. Malignancy risk in patients with giant cell arteritis: a population-based cohort study. Arthritis Care Res 2010;62:149-54.
20. Durand M, Thomas SL. Incidence of infections in patients with giant cell arteritis: a cohort study. Arthritis Care Res 2012;64:581-8.